AEGERION PHARMACEUTICALS

Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutics/pharmaceuticals to treat cardiovascular and metabolic diseases. It develops lomitapide/AEGR-733, a microsomal triglyceride transfer protein inhibitor small molecule drug for decreasing serum lipids, including cholesterol and triglycerides, as well as to treat atherosclerosis, dyslipidemia, obesity, and pancreatitis. The company also focuses on products for the evaluation and treatment of hyperlipidemia. Aegerion Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Bridgewater, New Jersey.

#SimilarOrganizations #People #Financial #Website #More

AEGERION PHARMACEUTICALS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Health Care Therapeutics

Founded:

2005-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.aegerion.com

Total Employee:

101+

Status:

Active

Contact:

(855) 305-2347

Email Addresses:

[email protected]

Total Funding:

63.68 M USD

Technology used in webpage:

SPF SSL By Default Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail Amazon Virginia Region Amazon Route 53 Smart App Banner OVH

Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

bioatlantis-logo

BioAtlantis

BioAtlantis is enagaged in the development of nutraceutical ingredients for the plant, human, and animal markets.

cequent-pharmaceuticals-logo

Cequent Pharmaceuticals

Cequent is a biopharmaceutical company pioneering the development of novel therapeutics to prevent and treat a wide range of human diseases.

galenea-logo

Galenea

Galenea is engaged in developing therapeutics for central nervous system diseases.

milestone-pharmaceuticals-logo

Milestone Pharmaceuticals

Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.

rinat-neuroscience-logo

Rinat Neuroscience

A leader in the development of therapeutic antibodies, spun out its key neuroscience assets under a broad license to Rinat.

vigeo-therapeutics-logo

Vigeo Therapeutics

Vigeo Therapeutics is a biopharmaceutical company developing novel therapeutic agents intended to treat advanced malignant tumors.

Current Advisors List

francesco-rubertis_image

Francesco Rubertis Investor @ Aegerion Pharmaceuticals
Board_member

sol-barer_image

Sol Barer Member of the Board of Directors @ Aegerion Pharmaceuticals
Board_member

not_available_image

Sandford ("Sandy") D. Smith Board of Directors @ Aegerion Pharmaceuticals
Board_member

david-i-scheer_image

David I. Scheer Chairman of the Board @ Aegerion Pharmaceuticals
Board_member

Current Employees Featured

not_available_image

Antonio M. Gotto Jr
Antonio M. Gotto Jr Weill Medical College of Cornell University @ Aegerion Pharmaceuticals
Weill Medical College of Cornell University

david-allmond_image

David Allmond
David Allmond President, EMEA @ Aegerion Pharmaceuticals
President, EMEA
2015-07-01

mary-szela_image

Mary Szela
Mary Szela Chief Executive Officer @ Aegerion Pharmaceuticals
Chief Executive Officer
2016-01-01

melissa-morandi_image

Melissa Morandi
Melissa Morandi Vice President Global Quality @ Aegerion Pharmaceuticals
Vice President Global Quality
2015-04-01

Stock Details

Company's stock symbol is NASDAQ:AEGR

Acquisitions List

Date	Company	Article	Price
2014-11-06	Myalept	Myalept acquired by Aegerion Pharmaceuticals	N/A

Investors List

alta-partners_image

Official Site Inspections

http://www.aegerion.com

Host Informations
Whois Informations

Loading ...